BMJ Best Practice

参考文献

关键文献

American Academy of Pediatrics; American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 8th ed. American Academy of Pediatrics and American College of Obstetricians and Gynecologists; 2017.

National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies. February 2019. http://www.nice.org.uk

Driscoll DA, Gross S. Clinical practice: prenatal screening for aneuploidy. N Engl J Med. 2009;360:2556-2562.

American Congress of Obstetricians and Gynecologists. Committee opinion no. 640: Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126:e31-e37.

National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. August 2015. http://www.nice.org.uk

National Institute for Health and Care Excellence. Antenatal and postnatal mental health: clinical management and service guidance. June 2015. Updated April 2018. http://www.nice.org.uk/

参考文章

1.  Posner SF, Johnson K, Parker C, et al. The national summit on preconception care: a summary of concepts and recommendations. Matern Child Health J. 2006;10(suppl):S197-S205.

2.  American Academy of Pediatrics; American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 8th ed. American Academy of Pediatrics and American College of Obstetricians and Gynecologists; 2017.

3.  Korenbrot CC, Steinberg A, Bender C, et al. Preconception care: a systematic review. Matern Child Health J. 2002;6:75-88.

4.  Johnson K, Posner SF, Biermann J, et al. Recommendations to improve preconception health and health care - United States. MMWR Recomm Rep. 2006;55:1-23.

5.  Kirkham C, Harris S, Grzybowski S. Evidence-based prenatal care - part II: third-trimester care and prevention of infectious diseases. Am Fam Physician. 2005;71:1555-1560.

6.  Gruslin A, Steben M, Halperin S, et al. Immunization in pregnancy. [Erratum in J Obstet Gynaecol Can. 2009;31:209]. J Obstet Gynaecol Can. 2008;30:1149-1154.

7.  National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies. February 2019. http://www.nice.org.uk

8.  Phelan ST. Components and timing of prenatal care. Obstet Gynecol Clin North Am. 2008;35:339-353.

9.  Lilford RJ, Kelly M, Baines A, et al. Effect of using protocols on medical care: randomised trial of three methods of taking an antenatal history. BMJ. 1992;305:1181-1184.

10.  Banks E, Meirik O, Farley T, et al. WHO study group on female genital mutilation and obstetric outcome. Female genital mutilation and obstetric outcome: WHO collaborative prospective study in six African countries. Lancet. 2006;367:1835-1841.

11.  Royal College of Obstetrics and Gynaecologists. Female genital mutilation and its management. Green-top guideline no. 53. July 2015. http://www.rcog.org.uk/

12.  Dowswell T, Carroli G, Duley L, et al. Alternative versus standard packages of antenatal care for low-risk pregnancy. Cochrane Database Syst Rev. 2015;(7):CD000934.

13.  American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Committee opinion no. 453: screening for depression during and after pregnancy. Obstet Gynecol. 2010;115:394-395.

14.  Yonkers KA, Wisner KL, Stewart DE, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009;31:403-413.

15.  American College of Obstetricians and Gynecologists Committee on Health Care for Underserved Women. ACOG committee opinion no. 343: psychosocial risk factors: perinatal screening and intervention. Obstet Gynecol. 2006;108:469-477.

16.  American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG committee opinion no. 566: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2013;121:1411–1414.

17.  American College of Obstetricians and Gynecologists. Risk factors for intrauterine growth restriction. Practice bulletin no. 12. Washington, DC: ACOG; 2000.

18.  Kirkham C, Harris S, Grzybowski S. Evidence-based prenatal care - part I: general prenatal care and counseling issues. Am Fam Physician. 2005;71:1307-1316.

19.  Kaiser L, Allen LH; American Dietetic Association. Position of the American Dietetic Association: nutrition and lifestyle for a healthy pregnancy outcome. J Am Diet Assoc. 2008;108:553-561.

20.  Fitzsimons KJ, Modder J; Centre for Maternal and Child Enquires. Setting maternity care standards for women with obesity in pregnancy. Semin Fetal Neonatal Med. 2010;15:100-107.

21.  Goodnight W, Newman R, Society of Maternal-Fetal Medicine. Optimal nutrition for improved twin pregnancy outcome. Obstet Gynecol. 2009;114:1121-1134.

22.  Goldstein RF, Abell SK, Ranasinha S, et al. Association of Gestational Weight Gain With Maternal and Infant Outcomes: A Systematic Review and Meta-analysis. JAMA. 2017 Jun 6;317(21):2207-2225.

23.  International Weight Management in Pregnancy (i-WIP) Collaborative Group. Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials. BMJ. 2017 Jul 19;358:j3119.

24.  Hodgetts VA, Morris RK, Francis A, et al. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. BJOG. 2015;122:478-490.

25.  Coletta JM, Bell SJ, Roman AS. Omega-3 fatty acids and pregnancy. Rev Obstet Gynecol. 2010;3:163-171.

26.  Zhou SJ, Yelland L, McPhee AJ, et al. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr. 2012;95:1378-1384.

27.  Royal College of Obstetricians and Gynaecologists. Vitamin D in pregnancy. Scientific impact paper no. 43. June 2014. http://www.rcog.org.uk/ (last accessed 5 April 2017).

28.  Conde-Agudelo A, Romero R, Kusanovic JP, et al. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;204:503.

29.  Rumbold A, Ota E, Nagata C, et al. Vitamin C supplementation in pregnancy. Cochrane Database Syst Rev. 2015;(9):CD004072.

30.  American College of Obstetricians and Gynecologists. ACOG committee opinion no. 462: moderate caffeine consumption during pregnancy. Obstet Gynecol. 2010;116:467-468.

31.  American College of Obstetricians and Gynecologists (ACOG). Committee opinion no. 471: smoking cessation during pregnancy. Obstet Gynecol. 2010;116:1241-1244.

32.  Department of Health. UK Chief Medical Officers’ low risk drinking guidelines. August 2016.

33.  Burns E, Gray R, Smith LA, et al. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction. 2010;105:601-614.

34.  Berghella V, Buchanan E, Pereira L, et al. Preconception care. Obstet Gynecol Surv. 2010;65:119-131.

35.  Academy of Breastfeeding Medicine Protocol Committee. Clinical protocol number #19: breastfeeding promotion in the prenatal setting. Breastfeed Med. 2009;4:43-45.

36.  Royal College of Obstetrics and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green-top guideline no. 37a. April 2015. http://www.rcog.org.uk/

37.  Royal College of Obstetrics and Gynaecologists. Air travel and pregnancy. Scientific impact paper 1. May 2013. http://www.rcog.org.uk

38.  Han S, Middleton P, Crowther CA. Exercise for pregnant women for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. 2012;(7):CD009021.

39.  Wiebe HW, Boulé NG, Chari R, et al. The effect of supervised prenatal exercise on fetal growth: a meta-analysis. Obstet Gynecol. 2015;125:1185-1194.

40.  Domenjoz I, Kayser B, Boulvain M. Effect of physical activity during pregnancy on mode of delivery. Am J Obstet Gynecol. 2014;211:401.e1-401.e11.

41.  U.S. Preventive Services Task Force. Screening for hepatitis B virus infection in pregnancy: reaffirmation recommendation statement. Am Fam Physician. 2010;81:502.

42.  Wagner CL, Greer FR; American Academy of Pediatrics Section on Breastfeeding. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008 Nov;122(5):1142-52. [Erratum in: Pediatrics. 2009 Jan;123(1):197.]

43.  ACOG Committee on Obstetric Practice. ACOG committee opinion no. 495: vitamin D: screening and supplementation during pregnancy. Obstet Gynecol. 2011;118:197-198.

44.  Ross AC, Taylor CL, Yaktine AL, et al. Dietary reference intakes for calcium and vitamin D. 1st ed. Washington, DC; 2011.

45.  Gharib H, Tuttle RM, Baskin HJ, et al. Subclinical thyroid dysfunction. J Clin Endocrinol Metab. 2005;90:581-585.

46.  Committee on Patient Safety and Quality Improvement, Committee on Professional Liability. ACOG committee opinion no. 381: subclinical hypothyroidism in pregnancy. Obstet Gynecol. 2007;110:959-960.

47.  Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14;291(2):228-38.

48.  Spong CY. Subclinical hypothyroidism: should all pregnant women be screened? Obstet Gynecol. 2005;105:235-236.

49.  Committee on Genetics. Committee Opinion No. 691: carrier screening for genetic conditions. Obstet Gynecol. 2017;129:e41-55.

50.  American College of Obstetricians and Gynecologists. Committee opinion no. 690: carrier screening in the age of genomic medicine. Obstet Gynecol. 2017;129:e35-e40.

51.  Committee on Genetics. Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine. Obstet Gynecol. 2017 Mar;129(3):e35-e40.

52.  American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 101: ultrasonography in pregnancy. Obstet Gynecol. 2009;113:451-461.

53.  Committee on Obstetric Practice. Committee Opinion No. 688: Management of Suboptimally Dated Pregnancies. Obstet Gynecol. 2017 Mar;129(3):e29-e32.

54.  Cargill Y, Morin L, Bly S, et al. Content of a complete routine second trimester obstetrical ultrasound examination and report. J Obstet Gynaecol Can. 2009;31:272-280.

55.  Torloni MR, Vedmedovska N, Merialdi M, et al; ISUOG-WHO Fetal Growth Study Group. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis. Ultrasound Obstet Gynecol. 2009;33:599-608.

56.  International Society of Ultrasound in Obstetrics and Gynecology. Performance of first-trimester fetal ultrasound scan. January 2013 [internet publication].

57.  Stalberg K, Axelsson O, Haglund B, et al. Prenatal ultrasound exposure and children's school performance at age 15-16: follow-up of a randomized controlled trial. Ultrasound Obstetr Gynecol. 2009;34:297-303.

58.  Davies GA, Maxwell C, McLeod L, et al. SOGC clinical practice guidelines: obesity in pregnancy. No. 239, February 2010. Int J Gynaecol Obstet.2010;110:167-173.

59.  Berghella V. Placenta previa, placenta accrete, and vas previa: obstetric evidence based guidelines. New York, NY: Informa Healthcare USA, Inc; 2009.

60.  Oyelese Y. Placenta previa: the evolving role of ultrasound. Ultrasound Obstet Gynecol. 2009;34:123-126.

61.  Driscoll DA, Gross S. Clinical practice: prenatal screening for aneuploidy. N Engl J Med. 2009;360:2556-2562.

62.  ACOG Committee on Practice Bulletins. ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217-227.

63.  Driscoll DA, Gross SJ; Professional Practice and Guidelines Committee. First trimester diagnosis and screening for fetal aneuploidy. Genet Med. 2008;10:73-75.

64.  Palomaki GE, Lee JE, Canick JA, et al; ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med. 2009;11:669-681.

65.  Gagnon A, Wilson RD, Audibert F, et al; Society of Obstetricians and Gynaecologists of Canada Genetics Committee. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30:918-949.

66.  American Congress of Obstetricians and Gynecologists. Committee opinion no. 640: Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol. 2015;126:e31-e37.

67.  Committee on Practice Bulletins—Obstetrics, Committee on Genetics, and the Society for Maternal-Fetal Medicine. Practice Bulletin No. 163: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016 May;127(5):e123-37.

68.  American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012 Dec;120(6):1532-4.

69.  American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459-1467.

70.  Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367:2175-2184.

71.  Committee on Genetics and the Society for Maternal-Fetal Medicine. Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. Obstet Gynecol. 2016 Dec;128(6):e262-e268.

72.  Cheschier N; ACOG Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin: neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). Int J Gynaecol Obstet. 2003;83:123-133.

73.  Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009 Apr;29(4):402-11.

74.  National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period. August 2015. http://www.nice.org.uk

75.  Moyer VA; U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:414-420.

76.  Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018 Feb;131(2):e49-e64.

77.  Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010 Nov 19;59(rr-10):1-36.

78.  National Institute for Health and Care Excellence. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. August 2008. http://www.nice.org.uk/

79.  American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S103-S105.

80.  Pavord S, Myers B, Robinson S, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588.

81.  American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 95: anemia in pregnancy. Obstet Gynecol. 2008;112:201-207.

82.  Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998;47:1-36.

83.  Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, et al. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015;(7):CD004736.

84.  Clinical Practice Obstetrics Committee; Maternal Fetal Medicine Committee; Delaney M, Roggensack A, Leduc DC, et al. Guidelines for the management of pregnancy at 41+0 to 42+0 weeks. J Obstet Gynaecol Can. 2008;30:800-823.

85.  American College of Obstetricians and Gynecologists. Practice bulletin no. 146: Management of late-term and postterm pregnancies. Obstet Gynecol. 2014 Aug;124(2 pt 1):390-6.

86.  Sui Z, Grivell RM, Dodd JM. Antenatal exercise to improve outcomes in overweight or obese women: a systematic review. Acta Obstet Gynecol Scand. 2012;91:538-545.

87.  Quinlivan JA, Julania S, Lam L. Antenatal dietary interventions in obese pregnant women to restrict gestational weight gain to Institute of Medicine recommendations: a meta-analysis. Obstet Gynecol. 2011;118:1395-1401.

88.  Racusin D, Stevens B, Campbell G, et al. Obesity and the risk and detection of fetal malformations. Semin Perinatol. 2012;36:213-221.

89.  National Institute for Health and Care Excellence. Antenatal and postnatal mental health: clinical management and service guidance. June 2015. Updated April 2018. http://www.nice.org.uk/

90.  Royal College of Obstetrics and Gynaecologists. Amniocentesis and chorionic villus sampling. Green-top guideline no. 8. June 2010. http://www.rcog.org.uk/

91.  Chitayat D, Langlois S, Wilson RD; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for fetal aneuploidy in singleton pregnancies. J Obstet Gynaecol Can. 2011;33:736-750.

92.  Gagnon A, Wilson RD, Allen VM,et al; Society of Obstetricians and Gynaecologists of Canada. Evaluation of prenatally diagnosed structural congenital anomalies. J Obstet Gynaecol Can. 2009;31:875-881, 882-889.

93.  Gruslin A, Steben M, Halperin S, et al; Infectious Diseases Committee of the Society of Obstetricians and Gynaecologists of Canada. Immunization in pregnancy. J Obstet Gynaecol Can. 2009;31:1085-1101.

94.  Wilson RD, Audibert F, Brock JA, et al; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies. J Obstet Gynaecol Can. 2015;37:534-552.

使用此内容应接受我们的免责声明